Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2009-02-09
2010-02-09
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S203100, C424S201100, C424S185100, C424S190100, C424S192100, C424S193100, C530S350000, C435S975000
Reexamination Certificate
active
07658934
ABSTRACT:
The present invention provides vaccines for immunizing a host, including humans, against disease caused by infection by a strain ofChlamydia, specificallyC. pneumoniae. The vaccine and method employ a full-length, 5′-truncated or 3′-truncated 76 kDa protein of a strain ofChlamydia pneumoniae. Modifications are possible within the scope of this invention.
REFERENCES:
patent: 5283185 (1994-02-01), Epand et al.
patent: 6521745 (2003-02-01), Murdin et al.
patent: 6559294 (2003-05-01), Griffais et al.
patent: 6693087 (2004-02-01), Murdin et al.
patent: 6808713 (2004-10-01), Murdin et al.
patent: 6822071 (2004-11-01), Stephens et al.
patent: 7019125 (2006-03-01), Murdin et al.
patent: 7081245 (2006-07-01), Murdin et al.
patent: 2002/0082402 (2002-06-01), Murdin et al.
patent: 2002/0094340 (2002-07-01), Murdin et al.
patent: 2002/0094965 (2002-07-01), Murdin et al.
patent: 2002/0099188 (2002-07-01), Murdin et al.
patent: 2002/0132994 (2002-09-01), Murdin et al.
patent: 2003/0100706 (2003-05-01), Murdin et al.
patent: 2004/0254130 (2004-12-01), Murdin et al.
patent: 0784059 (1997-07-01), None
patent: WO 88/09336 (1988-12-01), None
patent: WO 96/14831 (1996-05-01), None
patent: WO 98/58995 (1998-12-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 00/24765 (2000-05-01), None
patent: WO 00/27994 (2000-05-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 00/37494 (2000-06-01), None
patent: WO 00/46359 (2000-08-01), None
patent: WO 00/66739 (2000-11-01), None
patent: WO 01/21804 (2001-03-01), None
patent: WO 01/21811 (2001-03-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 01/46224 (2001-06-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 01/85972 (2001-11-01), None
patent: WO 02/02606 (2002-01-01), None
patent: WO 02/08267 (2002-01-01), None
U.S. Appl. No. 09/857,128, filed Sep. 20, 2001, Murdin et al.
U.S. Appl. No. 09/868,987, filed Dec. 23, 1999, Murdin et al.
U.S. Appl. No. 09/471,194, filed Dec. 23, 1999, Murdin et al.
U.S. Appl. No. 09/523,647, filed Mar. 10, 2000, Murdin et al.
U.S. Appl. No. 09/522,606, filed Mar. 10, 2000, Murdin et al.
U.S. Appl. No. 09/609,243, filed Jun. 30, 2000, Murdin et al.
U.S. Appl. No. 09/662,813, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,362, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,360, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,361, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/662,814, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/662,812, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/709,473, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/709,474, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/709,384, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/747,349, filed Dec. 22, 2000, Murdin et al.
Grayston et al., “Evidence that Chlamydia Pneumoniae causes Pneumonia and Bronchitis”,The Journal of Infectious Diseases, vol. 168(5):1231-1491 (1993).
Campos et al., “A Chlamydial Major Outer Membrane Protein Extract as a Trachoma Vaccine Candidate”,Investigative Ophthalmology&Visual Science, vol. 36(8) (1995).
Grayston et al., “A New Respiratory Tract Pathogen: Chlamydia Pneumonie StrainTWAR”,The Journal of Infectious Diseases, vol. 161, pp. 618-625 (1990).
T. Marrie, “State-of-the-Art Clinical Article”,Clinical Infectious Diseases, vol. 18, pp. 501-515 (1994).
Wang et al., “Microimmunofluorescence Serological Studies with the TWAR Organism”,Chlamydial Infections, pp. 329-333 (1986).
Saikku et al., “Serological Evidence of an Association of a Novel Chlamydia, TWAR, with Chronic Coronary Heart Disease and Acute Myocardial Infarction”,The Lancet, pp. 983-985 (1988).
Thom et al. “Association of Prior Infection with Chlamydia Pneumoniae and Angiographically Demonstrated Coronary Artery Diseases”,JAMA, vol. 268(1):68-72.
Kuo et al., “Demonstration of Chlamydia Pneumoniae in Atherosclerotic Lesions of Coronary Arteries”,The Journal of Infectious Diseases, vol. 167:841-849 (1993).
Kuo et al., “Detection of Chlamydia Pneumoniae in Aortic Lesions of Atherosclerosis by Immunocytochemical Stain”,Arteriosclerosis and Thrombosis, vol. 13(10):1501-1504 (1993).
Campbell et al., “Detection of Chlamydia Pneumoniae TWAR in Human Coronary Atherectomy Tissues”,The Journal of Infectious Diseases, vol. 172:585-588 (1995).
Chiu et al. “Chlamydia Pneumoniae, Cytomegalovirus, and Herpes Simplex Virus in Atherosclerosis of the Carotid Artery”,Circulation, vol. 96(7):2144-2148 (1997).
Ramirez, “Isolation of Chlamydia Pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis”,Ann. Intern. Med., vol. 125:979-982 (1996).
Jackson et al., Abst. K121, p. 272, 36thICAAC, Sep. 15-18, 1996, New Orleans.
Fong et al., “Rabbit Model for Chlamydia Pneumoniae Infection”,Journal of Clinical Microbiology, vol. 35(1):48-52 (1997).
Hahn et al., “Evidence for Chlamydia Pneumoniae Infection in Steroid-Dependent Asthma”,Ann. Allergy Asthma Immonol., vol. 80(1):45-49 (1998).
Hahn et al., “Association of Chlamydia Pneumoniae IgA Antibodies with Recently Symptomatic Asthma”,Epidemiol. Infect., vol. 117:513-517 (1996).
Bjoernsson et al., “Serology of Chlamydia in Relation to Asthma and Bronchial Hyperresponsiveness”,Scand. J. Infect. Dis., vol. 28:63-69 (1996).
Hahn, “Treatment of Chlamydia Pneumoniae Infection in Adult Asthma: A Before-After Trial”,J. Fam. Pract., vol. 41(4):345-351 (1995).
Linnamaeki et al., “Chlamydia Pneumoniae-Specific Circulating Immune Complexes in Patients with Chronic Coronary Heart Disease”,Circulation, vol. 87(4):1130-1134 (1993).
Saikku et al., “Annals of Internal Medicine”,American College of Physicians, vol. 116(4):273-278 (1992).
Melnick et al., “Past Infection by Chlamydia Pneumoniae Strain TWAR and Asymptomatic Carotid Atherosclerosis”,The American Journal of Medicine, vol. 95:499-504 (1993).
Shor et al., “Detection of Chlamydia Pneumoniae in Coronary Arterial Fatty Streaks and Atheromatous Plaques”,South African Medical Journal, vol. 82:158-161 (1992).
Allegra et al., “Acute Exacerbations of Asthma in Adults: Role of Chlamydia Pneumoniae Infection”,Eur. Respir. J., vol. 7(12):2165-2168 (1994).
Hahn et al., “Association of Chlamydia Pneumoniae (Strain TWAR) Infection with Wheezing, Asthmatic Bronchitis, and Adult-Onset Asthma”,JAMA, vol. 266(2):225-230 (1991).
Pal et al., “Intranasal Immunization Induces Long-Term Protection in Mice Against a Chlamydia Trachomatis Genital Challenge”,Infection and Immunity, vol. 64(12):5341-5348 (1996).
Jones et al., “Efficacy Trials with Tissue-Culture Grown, Inactivated Vaccines Against Chlamydial Abortion in Sheep”,Vaccine, vol. 13(8):715-723 (1955).
Igietseme et al., “Resolution of Murine Chlamydial Genital Infection by the Adoptive Transfer of a Biovar-Specific TH1 Lymphocyte Clone”,Regional Immunology, vol. 5:317-324 (1993).
Magee et al., “Chlamydia Trachomatis Pneumoniae in the Severe Combined Immunodeficiency (SCID) Mouse”, Reg. Immunol., vol. 5:305-311 (1993).
Gaydos et al., “Similarity of Chlamydia Pneumoniae Strains in the Variable Domain IV Region of the Major Outer Membrane Protein Gene”, Infection and Immunity, vol. 60(12):5319-5323 (1992).
Database Trembl “Online!” EBI, Hinxton, U.K.; May 1, 1999; XP002150537; CHLPN 76 KDA HOMOLOG—1 (CT622).
Perez, Melgosa M. et al., “Isolation and Characterization of a Gene Encoding a Chlamydia Pneumoniae 76-Kilodalton Protein Containing a Species-Specific Epitope”,Infection and Immunity, Mar. 1, 1994, U.S., American Society for Microbiology, Washington vol. 62, No. 3, pp. 880-886.
Kalman et al.,Nature Genetics, Apr. 1999, 21:385-389.
Casey et al., “Rates of Formation and Thermal Stabilities of RNA:DNA a
Dunn Pamela
Murdin Andrew D.
Oomen Raymond P.
Wang Joe
Graser Jennifer E
Sanofi Pasteur Limited
LandOfFree
Chlamydia antigens and protein vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlamydia antigens and protein vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and protein vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178893